CA
NZ
UK
AU
IND
US
Sight Sciences is trading lower in pre-market action even after the company delivered positive news on both the payer coverage and earnings fronts. Shares fell as much as 7.35% to $5.14 in pre-market trading, extending a 1.60% decline from the prior regular session, despite …
Akebia Therapeutics shares are trading sharply lower today, even though the company technically reported second-quarter results that beat consensus estimates on both revenue and earnings per share. The stock fell as much as 23.00% to $0.99 in pre-market trading, extending a 2.27% decline from …
Caris Life Sciences is trading sharply higher today after the company delivered a standout second-quarter report that topped Wall Street expectations on both revenue and profitability. Shares climbed as much as 13.80% in pre-market trading to $18.72, building on a modest 2.17% gain during …
ASP Isotopes is trading modestly higher today after announcing its upcoming participation in a major investor conference. Shares rose as much as 3.46% to $4.19 in pre-market trading, adding to a 5.59% decline in the prior regular session, though the stock remains well off …
Evolus is trading higher in pre-market action following a second-quarter report that showed accelerating growth and improving profitability. Shares rose as much as 5.69% to $6.53 in pre-market trading, building on a modest 0.98% gain in the prior regular session.
Charles River Laboratories (NYSE:CRL) shares surged more than 10% following second-quarter results that beat estimates across nearly every major metric, with non-GAAP earnings per share of 3.02 dollars topping the 2.74 dollar consensus by more than 10% and revenue of 1.00 billion dollars beating …
Jupiter Neurosciences (NASDAQ:JUNS) is a clinical-stage biopharmaceutical company headquartered in Jupiter, Florida, focused on developing innovative therapies for neurological and neurodegenerative disorders. The company's proprietary lead program, JOTROL, an enhanced-bioavailability resveratrol formulation, is currently in a Phase IIa clinical trial for Parkinson's disease, and …
LeMaitre Vascular (NASDAQ:LMAT) is a Burlington, Massachusetts-based medical device company that develops, manufactures, and markets a diversified portfolio of disposable and implantable devices for the treatment of peripheral vascular disease. Founded in 1983 by pioneering vascular surgeon George D. LeMaitre, the company offers more …
LivaNova (NASDAQ:LIVN) is a global medical technology company headquartered in London, United Kingdom, formed in 2015 through the merger of Sorin S.p.A. and Cyberonics, combining deep expertise in cardiovascular and neuromodulation therapies. The company operates through two core segments, Cardiopulmonary, which designs and manufactures …
Medline (NASDAQ:MDLN) is the largest provider of medical-surgical products and supply chain solutions in the United States, serving hospitals, surgical centers, physician offices, post-acute care facilities, and nursing homes both domestically and internationally. Founded in 1966 and headquartered in Northfield, Illinois, the company operates …
Please wait processing your request...